Back to Search
Start Over
Phytol from Scoparia dulcis prevents NF-κB-mediated inflammatory responses during macrophage polarization.
- Source :
-
3 Biotech [3 Biotech] 2024 Mar; Vol. 14 (3), pp. 80. Date of Electronic Publication: 2024 Feb 17. - Publication Year :
- 2024
-
Abstract
- Macrophages are primary immune cells that mediate a wide range of inflammatory diseases through their polarization potential. In this study, phytol isolated from Scoparia dulcis has been explored against 7-ketocholesterol and bacterial lipopolysaccharide-induced macrophage polarization in IC-21 cells. Isolated phytol has been characterized using GC-MS, TLC, HPTLC, FTIR, <superscript>1</superscript> H-NMR, and HPLC analyses. The immunomodulatory effects of viable concentrations of phytol were tested on oxidative stress, arginase activity, nuclear and mitochondrial membrane potentials in IC-21 cells in addition to the modulation of calcium and lipids. Further, gene and protein expression of atherogenic markers were studied. Results showed that the isolated phytol at a viable concentration of 400 µg/ml effectively reduced the production of nitric oxide, superoxide anion (ROS generation), calcium and lipid accumulation, stabilized nuclear and mitochondrial membranes, and increased arginase activity. The atherogenic markers including iNOS, COX-2, IL-6, IL-1β, MMP-9, CD36, and NF-κB were significantly downregulated at the levels of gene and protein expression, while macrophage surface and nuclear receptor markers (CD206, CD163, and PPAR-γ) were significantly upregulated by phytol pre-treatment in macrophages. Therefore, the present pharmacognostic study supports the role of phytol isolated from Scoparia dulcis in preventing M2-M1 macrophage polarization under inflammatory conditions, making it a promising compound.<br />Supplementary Information: The online version contains supplementary material available at 10.1007/s13205-024-03924-9.<br />Competing Interests: Conflict of interestThe authors declare that they have no conflict of interest in the publication.<br /> (© King Abdulaziz City for Science and Technology 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.)
Details
- Language :
- English
- ISSN :
- 2190-572X
- Volume :
- 14
- Issue :
- 3
- Database :
- MEDLINE
- Journal :
- 3 Biotech
- Publication Type :
- Academic Journal
- Accession number :
- 38375513
- Full Text :
- https://doi.org/10.1007/s13205-024-03924-9